Ove Mattsson - Biotage AB Insider

BITGF -- USA Stock  

USD 13.18  0.00  0.00%

Mr. Ove H. Mattsson no longer serves as Chairman of the Board of Directors of Biotage AB effective as of April 26, 2018. He has held the position since April 27, 2007. He was on the Companys Board for fourteen years serving as its Chairman until 2006. Mr. Mattsson is Management Consultant. He also serves as Board Member at Vironova Medical AB and Vironova AB. He is also Member of the Royal Swedish Academy of Engineering Sciences
Age: 77  Chairman Since 2007  Ph.D    
46 18 56 59 00  http://www.biotage.com
Mattsson has obtained a Doctorate of Philosophy degree and is Associate Professor in Organic Chemistry.

Management Efficiency

The company has return on total asset (ROA) of 9.72 % which means that it generated profit of $9.72 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 23.62 % meaning that it generated $23.62 on every $100 dollars invested by stockholders.
The company has accumulated 12.31 M in total debt with debt to equity ratio (D/E) of 16.5 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Biotage AB has Current Ratio of 2.81 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Similar Executives

Found 5 records


Huateng MaTencent Holdings Limited
Mark ZuckerbergFacebook
Chi LauTencent Holdings Limited

Entity Summary

Biotage AB , a life science company, provides solutions, knowledge, and experience in the areas of analytical chemistry, medicinal chemistry, peptide synthesis, separation, and purification in the United States, Europe, Japan, China, and internationally. It sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, and academic institutions and commercial, hospitalbio-analytical, and forensic laboratories, as well as laboratories within food and environmental analysis. Biotage AB operates under Medical Instruments Supplies classification in USA and traded on OTC Market. It employs 7 people.Biotage AB (BITGF) is traded on OTC Market in USA. It is located in Box 8 and employs 397 people.

Biotage AB Leadership Team

Karolina Lawitz, Member of the Board of Directors
NilsOlof Bjork, Director
Yvonne Martensson, Director
Steve Jordan, Chief Scientific Officer
Love Amcoff, Director, Employee Representative
Anders Wikstrom, Vice President - Operations
Thomas Eklund, Member of the Board of Directors
Lars Backman, Vice President of Corporate Development
Anders Walldov, Member of the Board of Directors
Ove Mattsson, Chairman of the Board of Directors
Peter Ehrenheim, Member of the Board of Directors
Torben Joergensen, President and CEO
Paul Belton, Vice President - Business Development
Malin Albertsson, Director, Employee Representative
Erika Johnson, CFO

Stock Performance Indicators

Current Sentiment - BITGF

Biotage AB Investor Sentiment

Macroaxis portfolio users are unresponsive in their opinion about investing in Biotage AB. What is your opinion about investing in Biotage AB? Are you bullish or bearish?
50% Bullish
50% Bearish

Biotage AB Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Biotage AB and Vedanta Limited. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Portfolio Quick Import module to import or update all your transactions via one easy-to-use interface.
Search macroaxis.com